Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Guangzhou’s Baird Medical Completes its First Thyroid Microwave Ablation in the US

publication date: Jan 23, 2024

Guangzhou Baird Medical Devices performed its first thyroid microwave ablation (MWA) procedure in the US. A China-US company, Baird’s MWA device is used to treat benign and malignant tumors including thyroid nodules, liver cancer, lung cancer and breast lumps. It is the first company awarded a Class III medical devices registration certificate in China for MWA medical devices that target thyroid nodules. Baird Medical says it has a 35% market share of microwave ablation devices in China. The company is approved for China and US use in MWA procedures for thyroid nodules. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital